Non-muscle myosin IIA is required for the development of the zebrafish glomerulus

Kidney International

Volumn 80, Issue 10, 2011, Pages 1055-1063

  Müller, Tobias ^a   Rumpel, Elisabeth ^a   Hradetzky, Susanne ^a   Bollig, Frank ^b   Wegner, Henny ^a   Blumenthal, Antje ^a   Greinacher, Andreas ^a   Endlich, Karlhans ^a   Endlich, Nicole ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEBBISTATIN; MYOSIN IIA; NON MUSCLE MYOSIN IIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUSAL ATTRIBUTION; CELL COUNT; CELL LOSS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; GLOMERULUS MALFORMATION; KIDNEY MALFORMATION; LARVA; MESANGIUM CELL; MYH9 GENE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE FUNCTION; ZEBRA FISH;

EID: 80255126246     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.256     Document Type: Article

References (50)

1. Cai Y, Rossier O, Gauthier NC et al. Cytoskeletal coherence requires myosin-IIA contractility. J Cell Sci 2010; 123: 413-423.
2. Uehara R, Goshima G, Mabuchi I et al. Determinants of myosin II cortical localization during cytokinesis. Curr Biol 2010; 20: 1080-1085.
3. Yu W, Shewan AM, Brakeman P et al. Involvement of RhoA, ROCK I and myosin II in inverted orientation of epithelial polarity. EMBO Rep 2008; 9: 923-929.
4. Shih W, Yamada S. Myosin IIA dependent retrograde flow drives 3D cell migration. Biophys J 2010; 98: L29-L31.
5. Lee CS, Choi CK, Shin EY et al. Myosin II directly binds and inhibits Dbl family guanine nucleotide exchange factors: a possible link to Rho family GTPases. J Cell Biol 2010; 190: 663-674.
6. Conti MA, Adelstein RS. Nonmuscle myosin II moves in new directions. J Cell Sci 2008; 121: 11-18. (Pubitemid 351265698)
7. Krendel M, Mooseker MS. Myosins: tails (and heads) of functional diversity. Physiology (Bethesda) 2005; 20: 239-251. (Pubitemid 41215198)
8. Althaus K, Greinacher A. MYH9-related platelet disorDers. Semin Thromb Hemost 2009; 35: 189-203.
9. Seri M, Pecci A, Di Bari F et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82: 203-215. (Pubitemid 36578709)
10. Toren A, Rozenfeld-Granot G, Rocca B et al. Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13. Blood 2000; 96: 3447-3451.
11. Epstein CJ, Sahud MA, Piel CF et al. Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med 1972; 52: 299-310.
12. Turi S, Kobor J, Erdos A et al. Hereditary nephritis, platelet disorDers and deafness-Epstein's syndrome. Pediatr Nephrol 1992; 6: 38-43.
13. Naito I, Nomura S, Inoue S et al. Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. J Clin Pathol 1997; 50: 919-922. (Pubitemid 27524012)
14. Yap DY, Tse KC, Chan TM et al. Epstein syndrome presenting as renal failure in young patients. Ren Fail 2009; 31: 582-585.
15. Peterson LC, Rao KV, Crosson JT et al. Fechtner syndrome-a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 1985; 65: 397-406. (Pubitemid 15163578)
16. Sekine T, Konno M, Sasaki S et al. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. Kidney Int 2010; 78: 207-214.
17. Kopp JB. Glomerular pathology in autosomal dominant MYH9 spectrum disorDers: what are the clues telling us about disease mechanism? Kidney Int 2010; 78: 130-133.
18. Conti MA, Even-Ram S, Liu C et al. Defects in cell adhesion and the visceral endoDerm following ablation of nonmuscle myosin heavy chain II-A in mice. J Biol Chem 2004; 279: 41263-41266. (Pubitemid 39313562)
19. Matsushita T, Hayashi H, Kunishima S et al. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. Biochem Biophys Res Commun 2004; 325: 1163-1171. (Pubitemid 39535885)
20. Drummond IA, Majumdar A, Hentschel H et al. Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 1998; 125: 4655-4667. (Pubitemid 29027196)
21. Kramer-Zucker AG, Wiessner S, Jensen AM et al. Organization of the pronephric filtration apparatus in zebrafish requires nephrin, podocin and the FERM domain protein mosaic eyes. Dev Biol 2005; 285: 316-329. (Pubitemid 41394022)
22. Hentschel DM, Mengel M, Boehme L et al. Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol 2007; 293: F1746-F1750. (Pubitemid 350086011)
23. Bollig F, Perner B, Besenbeck B et al. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros. Development 2009; 136: 2883-2892.
24. Skouloudaki K, Puetz M, Simons M et al. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci U S A 2009; 21: 8579-8584.
25. Ashworth S, Teng B, Kaufeld J et al. Cofilin-1 inactivation leads to proteinuria. PLoS One 2010; 9: e12626.
26. Drummond IA, Davidson AJ. Zebrafish kidney development. Methods Cell Biol 2010; 100: 233-260.
27. Ebarasi L, Oddsson A, Hultenby K et al. Zebrafish: a model system for the study of vertebrate renal development, function, and pathophysiology. Curr Opin Nephrol Hypertens 2011; 20: 416-424.
28. Perner B, Englert C, Bollig F. The Wilms tumor genes wt1a and wt1b control different steps during formation of the zebrafish pronephros. Dev Biol 2007; 309: 87-96. (Pubitemid 47302449)
29. Strilic B, Kucera T, Eglinger J et al. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009; 17: 505-515.
30. Huang Y, Shi H, Zhou H et al. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 2006; 107: 3564-3571.
31. Wang A, Ma X, Conti MA et al. Nonmuscle myosin II isoform and domain specificity during early mouse development. Proc Natl Acad Sci U S A 2010; 107: 14645-14650.
32. Fischer RS, Gardel M, Ma X et al. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 2009; 19: 260-265.
33. Vaughan MR, Quaggin SE. How do mesangial and endothelial cells form the glomerular tuft? J Am Soc Nephrol 2008; 19: 24-33.
34. Wilson CA, Tsuchida MA, Allen GM et al. Myosin II contributes to cell-scale actin network treadmilling through network disassembly. Nature 2010; 465: 373-377.
35. Esser S, Wolburg K, Wolburg H et al. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140: 947-959. (Pubitemid 28141231)
36. Satchell SC, Tasman CH, Singh A et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006; 69: 1633-1640.
37. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716. (Pubitemid 36278589)
38. Ghiggeri GM, Caridi G, Magrini U et al. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). Am J Kidney Dis 2003; 41: 95-104. (Pubitemid 36043356)
39. Scheinman JI, Fish AJ, Michael AF. The immunohistopathology of glomerular antigens. The glomerular basement membrane, collagen, and actomyosin antigens in normal and diseased kidneys. J Clin Invest 1974; 54: 1144-1154.
40. Tyagi I, Agrawal U, Amitabh V et al. Thickness of glomerular and tubular basement membranes in preclinical and clinical stages of diabetic nephropathy. Indian J Nephrol 2008; 18: 64-69.
41. Teng YH, Ang HS, Mao KZ et al. Glomerular basement membrane thickness in an Asian population using a novel image analysis software. Pathology 2009; 41: 342-347.
42. Moxey-Mims MM, Young G, Silverman A et al. End-stage renal disease in two pediatric patients with Fechtner syndrome. Pediatr Nephrol 1999; 13: 782-786.
43. Arrondel C, Vodovar N, Knebelmann B et al. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2002; 13: 65-74. (Pubitemid 34042012)
44. Gross O, Beirowski B, Harvey SJ et al. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int 2004; 66: 102-111. (Pubitemid 38870086)
45. Huang Y, Arora P, McCulloch CA et al. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. J Cell Sci 2009; 122: 1637-1646.
46. Meyer zum Gottesberge AM, Gross O, Becker-Lendzian U et al. Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab Invest 2008; 88: 27-37.
47. Leon C, Eckly A, Hechler B et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 2007; 110: 3183-3191. (Pubitemid 350106310)
48. Westerfield M. The Zebrafish Book, 4th edn. University of Oregon Press: Eugene, 2000.
49. Richardson KC, Jarett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 1960; 35: 313-323.
50. Sato T. A modified method for lead staining of thin sections. J Electron Microsc (Tokyo) 1968; 17: 158-159.